Abraham M - Search Results

1

Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.

Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL. Karni A, et al. Among authors: abraham m. J Neuroimmunol. 2004 Jan;146(1-2):189-98. doi: 10.1016/j.jneuroim.2003.10.036. J Neuroimmunol. 2004. PMID: 14698862

2

Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells.

Abraham M, Shapiro S, Karni A, Weiner HL, Miller A. Abraham M, et al. J Neuroimmunol. 2005 Jun;163(1-2):157-64. doi: 10.1016/j.jneuroim.2005.02.001. Epub 2005 Apr 2. J Neuroimmunol. 2005. PMID: 15885317

3

Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response.

Karni A, Abraham M, Monsonego A, Cai G, Freeman GJ, Hafler D, Khoury SJ, Weiner HL. Karni A, et al. Among authors: abraham m. J Immunol. 2006 Sep 15;177(6):4196-202. doi: 10.4049/jimmunol.177.6.4196. J Immunol. 2006. PMID: 16951385

4

In vitro induction of regulatory T cells by anti-CD3 antibody in humans.

Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner HL. Abraham M, et al. J Autoimmun. 2008 Feb-Mar;30(1-2):21-8. doi: 10.1016/j.jaut.2007.11.007. J Autoimmun. 2008. PMID: 18191540 Free PMC article.

5

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso AS, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL. Ochi H, et al. Among authors: abraham m. Nat Med. 2006 Jun;12(6):627-35. doi: 10.1038/nm1408. Epub 2006 May 21. Nat Med. 2006. PMID: 16715091

6

New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity.

Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso A, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL. Ochi H, et al. Among authors: abraham m. J Neurol Sci. 2008 Nov 15;274(1-2):9-12. doi: 10.1016/j.jns.2008.07.027. Epub 2008 Sep 18. J Neurol Sci. 2008. PMID: 18804221 Free PMC article. Review.

7

Natural and induced immunization against CCL20 ameliorate experimental autoimmune encephalitis and may confer protection against multiple sclerosis.

Abraham M, Karni A, Mausner-Fainberg K, Weiss ID, Peled A. Abraham M, et al. Clin Immunol. 2017 Oct;183:316-324. doi: 10.1016/j.clim.2017.09.018. Epub 2017 Sep 20. Clin Immunol. 2017. PMID: 28939272

8

Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.

Abraham M, Wald H, Vaizel-Ohayon D, Grabovsky V, Oren Z, Karni A, Weiss L, Galun E, Peled A, Eizenberg O. Abraham M, et al. Front Immunol. 2017 Nov 23;8:1432. doi: 10.3389/fimmu.2017.01432. eCollection 2017. Front Immunol. 2017. PMID: 29218043 Free PMC article.

9

Bio-markers of disease activity and response to therapy in multiple sclerosis.

Miller A, Glass-Marmor L, Abraham M, Grossman I, Shapiro S, Galboiz Y. Miller A, et al. Among authors: abraham m. Clin Neurol Neurosurg. 2004 Jun;106(3):249-54. doi: 10.1016/j.clineuro.2004.02.008. Clin Neurol Neurosurg. 2004. PMID: 15177778 Review. No abstract available.

10

IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner.

Weiss ID, Wald O, Wald H, Beider K, Abraham M, Galun E, Nagler A, Peled A. Weiss ID, et al. Among authors: abraham m. J Interferon Cytokine Res. 2010 Jun;30(6):439-49. doi: 10.1089/jir.2009.0084. J Interferon Cytokine Res. 2010. PMID: 20235626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,457 results

Search Page

Filters